Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Scandinavian Journal of Immunology|April 1, 1996
Induction of human cytotoxic T lymphocytes by oxidized low density lipoproteinsR Wu, R Giscombe, G Holm, et al.The Journal of Rheumatology|February 24, 2000
Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosisD Huang, R Giscombe, Y Zhou, et al.Clinical and Experimental Immunology|August 1, 1995
T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitisR Giscombe, J Grunewald, S Nityanand, et al.Journal of Internal Medicine|August 22, 2006
Characterization of the expanded T-cell populations in patients with Wegener's granulomatosisR Giscombe, X B Wang, M Kakoulidou, et al.Genes and Immunity|June 12, 2002
A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of proteinX B Wang, X Zhao, R Giscombe, et al.Clinical and Experimental Immunology|July 1, 1985
Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's diseaseE Jezewska, M Björkholm, R Giscombe, et al.Journal of Internal Medicine|December 20, 2007
Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravisX B Wang, R Pirskanen, R Giscombe, et al.Journal of Clinical Immunology|December 19, 1998
Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activityR Giscombe, S Nityanand, N Lewin, et al.Scandinavian Journal of Immunology|November 7, 2001
Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cellsX B Wang, C Y Zheng, R Giscombe, et al.Scandinavian Journal of Immunology|October 24, 2007
Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activationM Kakoulidou, R Giscombe, X Zhao, et al.Pageof 4